At the news
? NEUTRALIMPACT 4/10 PRESS-RELEASE filed Jun 2, 2026 at 07:05 ET
Lifecore Biomedical announced a manufacturing services agreement with a leading ophthalmic disease management provider for process development and tech transfer of a next-generation reformulation from vials to pre-filled syringes. This is the sixth late-stage pipeline addition in seven months, but no financial terms or revenue commitments were disclosed.
- Agreement covers process development and technical transfer services for an injectable ophthalmic product.
- Program involves transitioning a commercially approved product from vials to pre-filled syringes.
- This is the sixth late-stage pipeline addition in seven months.
- No financial terms, deal value, or revenue guidance were disclosed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access